Xiaodong Wang, Director at BeiGene, Ltd. (BGNE), sold 83,520 shares at $178.39 ($14.7M) on 2025-01-07, disclosed to the SEC on 2025-01-08.
Scheduled sale ($14.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $175.46 | 19,251 | $3.4M | 22.9% |
| 2 | $175.46 | 19,251 | $3.4M | 22.9% |
| 3 | $176.67 | 11,310 | $2.0M | 13.6% |
| 4 | $176.67 | 11,310 | $2.0M | 13.6% |
| 5 | $177.42 | 4,260 | $756K | 5.1% |
| 6 | $177.42 | 4,260 |
| $756K |
| 5.1% |
| 7 | $178.39 | 5,638 | $1.0M | 6.8% |
| 8 | $178.39 | 5,638 | $1.0M | 6.8% |
| 9 | $179.18 | 1,301 | $233K | 1.6% |
| 10 | $179.18 | 1,301 | $233K | 1.6% |
| Total | $176.50 avg | 83,520 | $14.7M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |